CAS NO: | 105637-50-1 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
1 g | 电议 |
生物活性 | ML-9 is a selective and potent inhibitor ofAktkinase, inhibitsmyosinlight-chain kinase (MLCK) and stromal interaction molecule 1 (STIM1) activity[3]. ML-9 inhibits inhibits MLCK,PKAandPKCactivity withKivalues of 4, 32 and 54 μM, respectively[1]. ML-9 inducesautophagyby stimulating autophagosome formation and inhibiting their degradation[3]. | ||||||||||||||||
体外研究 (In Vitro) | ML9 (0-100 μM; 0-24 hours) has no reduction in cardiomyocyte viability, 50-100 μM significantly induces cell death[2].ML9 (50 μM; 1-4 hours) significantly increases cleaved caspase-3 levels, decreased STIM1 protein levels by about 42%[2]. Cell Viability Assay[1]
Apoptosis Analysis[1]
| ||||||||||||||||
分子量 | 361.29 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C15H18Cl2N2O2S | ||||||||||||||||
CAS 号 | 105637-50-1 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 83.33 mg/mL(230.65 mM;Need ultrasonic) H2O : ≥ 5 mg/mL(13.84 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|